Shitota et al. reported that mortalin is expressed in aggressive and metastatic cancer cells and can bind to unique anti-mortalin antibodies (MotAbs), leading to their internalization into cells (Shiota et al., 2007). This evidence concerns the gene HSPA9 and cancer.